xylazine has been researched along with Retinal Diseases in 2 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Retinal Diseases: Diseases involving the RETINA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bell, BA | 1 |
Bonilha, VL | 1 |
Hagstrom, SA | 1 |
Anand-Apte, B | 1 |
Hollyfield, JG | 1 |
Samuels, IS | 1 |
Kommonen, B | 1 |
Raitta, C | 1 |
2 other studies available for xylazine and Retinal Diseases
Article | Year |
---|---|
Prolonged ocular exposure leads to retinal lesions in mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Anesthetics, Combined; Anesthetics, Dissociative; Animals; Bio | 2019 |
Electroretinography in Labrador retrievers given ketamine-xylazine anesthesia.
Topics: Animals; Dog Diseases; Dogs; Electroretinography; Female; Ketamine; Male; Photic Stimulation; Retina | 1987 |